Athenex, Inc. (ATNX) SEC Filing 8-K Material Event for the period ending Tuesday, May 9, 2023

Athenex, Inc.

CIK: 1626450 Ticker: ATNX

View differences made from one to another to evaluate Athenex, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Athenex, Inc..


Assess how Athenex, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Athenex, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Material Contracts, Statements, Certifications & more

Athenex, Inc. provided additional information to their SEC Filing as exhibits

Ticker: ATNX
CIK: 1300699
Form Type: 8-K Corporate News
Accession Number: 0001193125-23-150484
Submitted to the SEC: Mon May 22 2023 4:15:56 PM EST
Accepted by the SEC: Mon May 22 2023
Period: Tuesday, May 9, 2023
Industry: Pharmaceutical Preparations
  1. Bankruptcy or Receivership
  2. Event for Officers
  3. Financial Exhibit
  4. Financial Obligation Increase
  5. Listing Status
  6. New Costs

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: